Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generation of Blood Vascular Endothelial-Neural 3D Organoids by Serial Induction of Differentiation on Human iPSC-Derived Embryoid Bodies.

Cells·2026
Same author

Functional analysis of germline RUNX1 variants identified in individuals with suspected familial platelet disorder.

Blood advances·2026
Same author

Extracellular Vesicles From Metabolically Healthy Obesity Convey Distinct Molecular Signals That Initiate Endothelial Dysfunction: A Multi-Omics Study in Adults of African Ancestry.

bioRxiv : the preprint server for biology·2026
Same author

Sex effects on gene expression across the human cerebral cortex at cell type resolution.

Science (New York, N.Y.)·2026
Same author

PRMT5 inhibition impairs Fanconi Anemia pathway-mediated homologous recombination and enhances the antitumor efficacy of Temozolomide in glioblastoma.

Cell death & disease·2026
Same author

Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy Volunteers.

Research square·2026

Related Experiment Video

Updated: Sep 12, 2025

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

7.7K

CBFβ-SMMHC-driven leukemogenesis requires enhanced RUNX1-DNA binding affinity in mice.

Tao Zhen1, Yaqiang Cao2, Tongyi Dou3

  • 1Oncogenesis and Development Section, Translational and Functional Genomics Branch, National Human Genome Research Institute (NHGRI), NIH, Bethesda, Maryland, USA.

The Journal of Clinical Investigation
|August 5, 2025
PubMed
Summary

The leukemia protein CBFβ-SMMHC drives cancer by increasing RUNX1

Keywords:
GeneticsHematologyLeukemiasMouse modelsTranscriptomics

More Related Videos

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.0K
Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production
08:22

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production

Published on: May 31, 2020

5.2K

Related Experiment Videos

Last Updated: Sep 12, 2025

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

7.7K
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.0K
Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production
08:22

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production

Published on: May 31, 2020

5.2K

Area of Science:

  • Hematology
  • Molecular Biology
  • Cancer Research

Background:

  • The CBFB-MYH11 fusion gene is central to inv(16) acute myeloid leukemia (AML).
  • The precise mechanism by which CBFB-MYH11 drives leukemogenesis, particularly its interaction with RUNX1, remains incompletely understood.

Purpose of the Study:

  • To elucidate the role of the chimeric protein CBFβ-SMMHC in leukemogenesis.
  • To investigate how CBFβ-SMMHC influences RUNX1 activity and DNA binding.
  • To identify the key molecular events linking CBFβ-SMMHC to leukemia development.

Main Methods:

  • In vitro binding assays to assess RUNX1-DNA interaction.
  • Studies in myeloid progenitor cells from mice expressing CBFβ-SMMHC.
  • Leukemia induction in mouse models with wild-type and mutated Runx1.
  • Transcriptomic analysis to identify affected gene expression pathways.

Main Results:

  • CBFβ-SMMHC enhances the binding affinity of RUNX1 to its target DNA.
  • Leukemogenic potential of CBFβ-SMMHC correlates with its ability to boost RUNX1 DNA binding.
  • Transcriptomic alterations in leukemic cells involve inflammatory response and CBFA2T3 target genes.
  • A Runx1 mutation impairing DNA binding prevents CBFβ-SMMHC-induced leukemia.

Conclusions:

  • Enhancing RUNX1 DNA binding affinity is a critical mechanism for CBFβ-SMMHC-mediated leukemogenesis.
  • RUNX1-DNA interaction is a potential therapeutic target for inv(16) AML.
  • The findings provide new insights into the molecular pathogenesis of this leukemia subtype.